Suppr超能文献

乳腺淋巴瘤:原发性和继发性累及

Lymphomas of the breast: primary and secondary involvement.

作者信息

Domchek Susan M, Hecht Jonathan L, Fleming Mark D, Pinkus Geraldine S, Canellos George P

机构信息

Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

出版信息

Cancer. 2002 Jan 1;94(1):6-13. doi: 10.1002/cncr.10163.

Abstract

BACKGROUND

The involvement of the breast by lymphoma is a rare form of extralymph node lymphoma and represents either primary disease or systemic involvement. The authors hypothesized that screening mammography may influence the detection of lymphomatous involvement of the breast.

METHODS

All patients (n = 81 patients) who were diagnosed with lymphomatous involvement of the breast at the study institution between 1988 and 1999 were evaluated retrospectively.

RESULTS

Clinical information was available for 73 patients who could be classified into three major groups according to their diagnosis: primary breast lymphoma (PBL) (44%), breast involvement from disseminated disease at the time of initial diagnosis (29%), and recurrence of preexisting lymphoma to the breast (27%). The majority of PBL were of intermediate or high grade, and the majority of disseminated lymphomas involving the breast were of low grade. Lymphomatous recurrence to the breast was slightly more likely to be of intermediate grade rather than low grade. In 91% of patients, the diagnosis of lymphoma was made after the evaluation of a palpable mass. All patients who were identified after the evaluation of an abnormal screening mammogram (9%) had low-grade lymphomas. Of the 32 patients with PBL, screening mammography discovered only 1. Nineteen percent of patients with PBL also had a history of an autoimmune disorder.

CONCLUSIONS

These findings suggest that screening mammography has not altered substantially the detection of breast lymphoma. The clinical outcome of patients with breast lymphoma is dependent on histology and appears to parallel that of patients with lymphoma of similar histology involving other sites.

摘要

背景

乳腺受淋巴瘤累及是淋巴结外淋巴瘤的一种罕见形式,可表现为原发性疾病或全身性累及。作者推测乳腺钼靶筛查可能会影响乳腺淋巴瘤累及情况的检出。

方法

对1988年至1999年间在研究机构被诊断为乳腺淋巴瘤累及的所有患者(n = 81例)进行回顾性评估。

结果

73例患者有临床资料,根据诊断可分为三大组:原发性乳腺淋巴瘤(PBL)(44%)、初诊时弥漫性疾病累及乳腺(29%)、既往淋巴瘤复发至乳腺(27%)。大多数PBL为中级或高级别,大多数累及乳腺的弥漫性淋巴瘤为低级别。淋巴瘤复发至乳腺更可能为中级而非低级别。91%的患者在对可触及肿块进行评估后确诊为淋巴瘤。在对异常乳腺钼靶筛查进行评估后确诊的所有患者(9%)均为低级别淋巴瘤。在32例PBL患者中,乳腺钼靶筛查仅发现1例。19%的PBL患者也有自身免疫性疾病史。

结论

这些发现表明,乳腺钼靶筛查并未显著改变乳腺淋巴瘤的检出情况。乳腺淋巴瘤患者的临床结局取决于组织学类型,似乎与累及其他部位的类似组织学类型淋巴瘤患者的结局相似。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验